---

Company Profile - Allergan, Inc.

2525 Dupont Dr.
Irvine, CA 92612-1599

Phone: 714-246-4500
Fax: 714-246-4971
Website: www.allergan.com
Ticker Symbol: AGN

Key Facts

Botox, Allergan’s first-ever blockbuster drug, is expected to earn more than $600 million by 2005.
In a recent survey, ophthalmologists rated Allergan’s sales force as the best in the industry.
About 52 percent of the company’s sales are foreign.
Key Financial Facts
2001 revenue: $1,746 million
1-yr growth rate: 7 percent

Personnel Highlights
Number of employees: 6,436
1-yr. growth rate: 4 percent

Company Overview
The name Allergan is fast becoming synonymous with Botox—the name of the anti-wrinkle treatment that has created a sensation among aging celebrities and is now taking the place of Tupperware as this generation’s favorite theme party.

Allergan does its business mostly in the specialty markets of ophthalmology and dermatology. Eye care products alone—such as medications, surgical equipment, contact lenses, and intraocular lenses—make up two-thirds of the company’s sales. Allergan also develops products for skin conditions such as psoriasis, acne, and sun damage.

In 2002, Allergan announced that its eye care and pharmaceuticals divisions will be divided into separately traded companies. It also spun off its optical medical device unit—now called Advanced Medical Optics—in order to focus its time and money on the pharmaceutical business.

Major Line of Business :Biotechnology & Pharmaceuticals

Send additions, corrections, or comments to: exec@3dnet.org.